Pharmaceutical middle men reforms would save patients and taxpayers billions
PBMs, the goliath health insurance middle-men wedged between plan managers, drug manufacturers, patients and pharmacies, make huge profits by forcing pharmacies to pay back a portion of drug sales after the sale has been completed…Read More.
PBMs: Their Role, the Problems, and How Practices Can Work With Them
With the increasing prevalence of oral oncolytics, PBMs and community oncologists have seen a concurrent increase in their mutual interaction. Each can rail against the other, claiming better, faster, and more cost-effective care, or community oncologists can find a way to co-exist with and manage PBMs in a manner that would benefit patients and their practice….Read More.
Hospital Impact—Pharmacy benefit managers are a lot like car dealers
Like a car dealership, it’s hard to know a PBM’s actual costs or how that impacts what patients pay…Read More.
AMA, AHA Call For Drug Pricing Transparency, Increased Competition
Inside Health Policy
Representatives from the American Medical Association and the American Hospital Association called for increased drug pricing transparency and reduced regulations to increase competition at a panel on Monday (Sept. 25) on the cost of drugs at America’s Health Insurance Plans’ Medicare conference…Read More.
Want to Bring Down Drug Prices? Go After the Middleman
The American Prospect
“Pharmacy benefit managers”—companies that claim to lower prices—actually jack them up…Read More.
Hospital Impact—PBMs are worsening the opioid epidemic
For Americans younger than 50, the leading cause of death used to be injuries caused by accidents. Now, the biggest killer isn’t car crashes or ladder falls—it’s drug overdoses…Read More.
Middlemen Who Save $$ On Medicines — But Maybe Not For You
Kaiser Health News
Pharmacy benefit managers — companies that are often unnoticed and even less understood by most consumers — hold an important place in the prescription drug-pricing pipeline…Read More.
Market Reforms To Improve Pharmaceutical Outcomes
The drama of “repeal and replace” resembled an unfunny version of a Monty Python skit, continuously claiming that it was “not dead yet”, and even that it was “getting better” only to be put out of its misery in the end…Read More.
Price Transparency Is Critical to Drug Pricing Solutions
Prescription drug costs are a hot political issue, not as much because of the share of the U.S. health care dollar they consume but because consumers pay a larger share of their drug costs out of pocket than they do for other health care…Read More.